www.fdanews.com/articles/159850-new-drug-shows-early-promise-in-treating-parkinsons-psychosis
New Drug Shows Early Promise in Treating Parkinson’s Psychosis
November 4, 2013
An experimental drug called pimavanserin has passed a Phase III trial and appears to lessen Parkinson’s symptoms such as hallucinations and delusions.
HealthDay
HealthDay